Val Ferro read Biochemistry at the University of Aberdeen (BSc Hons 1985) and carried out postgraduate research into Tumour Biology at the University of St. Andrews. (PhD, 1989). She moved to the University of Strathclyde in 1989 as a Postdoctoral Research Fellow, managing commercially-funded projects on vaccine development. Current research interests within Dr Ferro's group focuses on three main areas: development of non-invasive human and veterinary vaccines, development of anti-fertility vaccines and natural product research.
Val teaches at both undergraduate (Years 1 and 2) and postgraduate level.
"Indication of efficacy of MTL004-NIV in a lung cancer model" Morvus Technology Ltd
"Demonstration of a platform enabling delivery system for non invasive drug delivery to the lungs" Scottish Enterprise: Proof of Concept
Publications
Mann JF, Shakir E, Carter KC, Mullen AB, Alexander J, Ferro VA. (2009) Lipid vesicle size of an oral influenza vaccine vehicle influences the Th1/Th2 bias in the immune response and protection against infection. Vaccine27, 3643-3649 [DOI: 10.1016/j.vaccine.2009.03.040]
Khan MA, Ogita K, Ferro VA, Kumasawa K, Tsutsui T, Kimura T. (2008) Immunisation with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes in saline suppresses rodent fertility. Vaccine26, 1365-1374 [DOI: 10.1016/j.vaccine.2007.12.052]
Bennett E, Mullen AB, Ferro VA (2009) Translational modifications to improve vaccine efficacy in an oral influenza vaccine. Methods49, 322-327
Mann JF, Acevedo R, Campo JD, Pérez O, Ferro VA. (2009) Delivery systems: a vaccine strategy for overcoming mucosal tolerance?. Expert Review of Vaccines8, 103-112 Published (review)
Das, B., Tandon, V., Lyndem, L.M., Gray, A.I., Ferro, V.A. (2009) Phytochemicals from Flemingia vestita (Fabaceae) and Stephania glabra (Menispermeaceae) alter cGMP concentration in the cestode Raillietina echinobothrida. Comparative Biochemistry and Physiology - Part C: Toxicology and Pharmacology149, 397-403
Ferro, V. A. & Garside, D. A. (2011) Reproductive component vaccine developments for contraceptive and non-contraceptive uses. Expert Opinion on Therapeutic Patents21, 1473-1482 [DOI: 10.1517/13543776.2011.594042]
Mann JF, Shakir E, Carter KC, Mullen AB, Alexander J, Ferro VA. (2009) Lipid vesicle size of an oral influenza vaccine vehicle influences the Th1/Th2 bias in the immune response and protection against infection. Vaccine27, 3643-3649 [DOI: 10.1016/j.vaccine.2009.03.040]
Khan MA, Ogita K, Ferro VA, Kumasawa K, Tsutsui T, Kimura T. (2008) Immunisation with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes in saline suppresses rodent fertility. Vaccine26, 1365-1374 [DOI: 10.1016/j.vaccine.2007.12.052]
Bennett E, Mullen AB, Ferro VA (2009) Translational modifications to improve vaccine efficacy in an oral influenza vaccine. Methods49, 322-327
Mann JF, Acevedo R, Campo JD, Pérez O, Ferro VA. (2009) Delivery systems: a vaccine strategy for overcoming mucosal tolerance?. Expert Review of Vaccines8, 103-112 Published (review)
Das, B., Tandon, V., Lyndem, L.M., Gray, A.I., Ferro, V.A. (2009) Phytochemicals from Flemingia vestita (Fabaceae) and Stephania glabra (Menispermeaceae) alter cGMP concentration in the cestode Raillietina echinobothrida. Comparative Biochemistry and Physiology - Part C: Toxicology and Pharmacology149, 397-403
Ferro, V. A. & Garside, D. A. (2011) Reproductive component vaccine developments for contraceptive and non-contraceptive uses. Expert Opinion on Therapeutic Patents21, 1473-1482 [DOI: 10.1517/13543776.2011.594042]
Reinaldo Acevedo, Belkis Romeu, Judith del Campo, Elizabeth Gonzales, Julio Balbao, Caridad Zayas, Maribel Cuello, Osmir Cabrera, Miriam Lastre, Valerie A Ferro, Oliver Perez (2009) Adjuavants: an essential component of neisseria vaccines. VacciMonitor18, 93-96
